UPDATE: BMO Capital Starts Vertex (VRTX) at Market Perform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to UPDATE: BMO Capital Starts Vertex (VRTX) at Market Perform

Vertex Pharma (VRTX) Enters Reimbursement Agreement in Spain for KAFTRIO in Combination With Ivacaftor

November 19, 2021 6:04 AM EST

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the Spanish government has approved terms for the... More

Piper Sandler Downgrades Vertex (VRTX) to Neutral

November 18, 2021 4:09 PM EST

Piper Sandler analyst Do Kim downgraded Vertex (NASDAQ: VRTX) from Overweight to Neutral with a price target of $218.00 (from $323.00).

For an analyst ratings summary and ratings history on Vertex click here. For more ratings news on Vertex click here.

Shares of Vertex closed at $188.25 yesterday.

... More

Truist Provides Follow Up Abbvie (ABBV) Triple Data

November 17, 2021 10:24 AM EST

Truist Securities analyst Robyn Karnauskas had a follow up on Abbvie (NYSE: ABBV) after taking to management. The trial is on track for internal readouts, while the data release timings under debate.

Company remains on track to see POC data... More

Vertex Pharma (VRTX) Sees Early Gains, Possible on Competitor Delay

November 17, 2021 9:40 AM EST

Vertex Pharma (NASDAQ: VRTX) strength could be tied to a possible delay with AbbVie (NYSE: ABBV) triple Phase 2 trial for CF. Shares up 3.2%.

... More